Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.

Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.

Abstract: [Problems] To provide a method for treating and/or preventing osteoporosis with teriparatide or a salt thereof, the method having excellent safety and/or efficacies. [Solving Means] A method for treating and/or preventing osteoporosis in which teriparatide or a salt thereof is an active ingredient, including administering teriparatide or a salt thereof in a unit dose of 28.2 ?g at a frequency of twice a week.

Abstract: The sulfoneamide compounds having the following Formula (1), which can be used as an effective component of a CaSR antagonizing agent useful for prophylaxis and/or treatment of bone disorders including osteoporosis and etc., are provided. The compounds have an excellent activity of promoting PTH secretion. In addition, the compounds are useful as an effective component of a medicament for the prophylaxis and/or treatment of bone disorders such as osteoporosis, bone fracture, hypoparathyroidism and the like.

Abstract: The sulfoneamide compounds having the following Formula (1), which can be used as an effective component of a CaSR antagonizing agent useful for prophylaxis and/or treatment of bone disorders including osteoporosis and etc., are provided. The compounds have an excellent activity of promoting PTH secretion. In addition, the compounds are useful as an effective component of a medicament for the prophylaxis and/or treatment of bone disorders such as osteoporosis, bone fracture, hypoparathyroidism and the like.

Abstract: A back pasting apparatus which uses a back pasting adhesive tape and is intended to make the apparatus compact and to improve back pasting quality. A guide rail (16) movable back and forth with respect to a frame (14) is provided. A paper table (15) arranged opposite to the guide rail (16) is biased by a spring or the like in the direction of the guide rail (16). The guide rail (16) and a clamp (22) are driven by a drive mechanism. First, a back pasting adhesive tape (30) is fed by a tape feeder into the guide groove (19) of the guide rail (16). As the clamp (22) lowers, the cover of papers (17) is pressed against the adhesive tape (30). The guide rail (16) is moved down along the grooves (20, 20) before being moved forward. As a result, only the paper table (15) is pressed down and moved back so that the adhesive tape (30) is pressed against the back and back cover of the papers (17).